• 대한심장학회 KSC
• 대한부정맥학회 KHRS
• 대한소아심장학회 KPHS
• 대한심부전학회 KSHF
• 대한심혈관중재학회 KSIC
• 심장대사증후군학회 KSCMS
• 한국심초음파학회 KSE
• 한국지질∙동맥경화학회 KSoLA

[ACC Together with KSC/KSE 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.300C
ATTR Cardiac Amyloidosis: Not to Be Missed Any More
Chairperson(s)	Ana Barac, Hae Ok Jung
Panel	Darae Kim, Jung-Woo Son
09:35-09:47	Diverse Manifestations of Cardiac Amyloidosis	Hyung Yoon Kim / Chonnam National Univ., Korea
09:47-09:59	Diagnostic Strategies in Clinical Diagnosis	Jordan Ray / Mayo Clinic, USA
09:59-10:11	Use of Imaging to Guide Treatment	Jung Hyun Choi / Pusan National Univ., Korea
10:11-10:20	Discussion

[ACC Together with KSC/KSHF 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.102
Management of Acute Decompensated Heart Failure
Chairperson(s)	Paul Mather, Dong Ju Choi
Panel	Min-Seok Kim
08:40-08:55	Hemodynamic Assessment	Paul Mather / Univ. of Pennsylvania, USA
08:55-09:02	Discussion
09:02-09:17	Inotropic Support and Transition to Oral Medications	Michael Genuardi / Univ. of Pennsylvania, USA
09:17-09:24	Discussion

[ACC Together with KSC/KSHF 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.102
New Heart Failure Therapies
Chairperson(s)	Paul Mather, Seok Min Kang
09:35-09:50	How and When to Initiate 4-Pillar Therapy?	Hyun-Jai Cho / Seoul National Univ., Korea
09:50-09:57	Discussion
09:57-10:12	The Role of SGLT2 Inhibitors and ARNI’s in the Management of Heart Failure: Tips From the Experts	Michael Genuardi / Univ. of Pennsylvania, USA
10:12-10:20	Discussion

[ACC Together with KSC/KSE 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.300C
Myocarditis: Learning from Our Diverse Clinical Experience
Chairperson(s)	Y.S. Chandrashekhar, Sangchol Lee
Panel	Hyun-Jung Lee, Jae Yeong Cho
08:40-08:50	Case: COVID and Myocarditis	In-Cheol Kim / Keimyung Univ., Korea
08:50-09:00	Case: Inflammatory Disease Affecting the Heart	Leslie Cooper / Mayo Clinic, USA
09:00-09:10	Case: Cancer Treatment and Myocarditis	Ana Barac / Georgetown Univ., USA
09:10-09:25	Discussion

[ACC Together with KSC/KHRS 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.103
Is Rate Control Dead?
Chairperson(s)	Fred Kusumoto, Hui Nam Pak
Panel	Changsheng Ma, Jong Sung Park
08:40-08:50	Patient Selection for Rate Control	Litsa Lambrakos / Univ. of Miami Health System, USA
08:50-09:00	Pharmacologic Strategies for Rate Control	Eue-Keun Choi / Seoul National Univ., Korea
09:00-09:10	Role of AVN Ablation in 2022: Benefits and Consequences	Kenneth Bilchick / Univ. of Virginia, USA
09:10-09:25	Discussion

[ACC Together with KSC/KHRS 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.103
Sudden Death: ICDs and?
Chairperson(s)	Rungroj Krittayaphong, Gi Byoung Nam
Panel	Freddy Del-Carpio Munoz, Namsik Yoon
09:35-09:45	Nondevice Therapies and SCD Prevention	Jong-Il Choi / Korea Univ., Korea
09:45-09:55	ICDs in NICM: Who and When	Dan Sorajja / Mayo Clinic, USA
09:55-10:05	ICDs in Channelopathies and HCM	Martin Maron / Tufts Medical Center, USA
10:05-10:20	Discussion

[Basic Research Hot Session 1]		Apr. 15 (Fri.) 08:40-10:20 Rm.105
Regeneration of Cardiac Tissue
Chairperson(s)	김효수, 권영근
Panel	박성하, 장기육, 장우철, 한정규
08:40-09:00	Regeneration of Infarcted Mouse Hearts by Cardiovascular Tissue Formed via the Direct Reprogramming of Mouse Fibroblasts	Young Sup Yoon / Emory Univ., Korea
09:00-09:20	Human iPSC-based Cardiac Microphysiological System for Disease Modeling and Space Biology	Deok-Ho Kim / Johns Hopkins Univ., USA
09:20-09:40	Mussel-Derived Adhesive Protein as an Innovative Functional Biomaterial for Effective Cardiac Tissue Regeneration	차형준 / POSTECH
09:40-10:00	In vivo Therapeutic Genome Editing via CRISPR/Cas9 Magnetoplexes for Myocardial Infarction	김종필 / 동국대학교
10:00-10:10	Discussion

[Women Heart Disease]		Apr. 15 (Fri.) 08:40-10:20 Rm.203
Pregnancy Associated Cardiovascular Risk
Chairperson(s)	홍경순, 김명아
Panel	김미나, 박상민, 변영섭
08:40-08:58	Pregnancy Number and Cardiovascular Risk	김학령 / 서울의대
08:58-09:16	Preeclampsia and Long-term Cardiovascular Disease	홍기림 / 차의대
09:16-09:34	Peripartum Cardiomyopathy in Korea	나진오 / 고려의대
09:34-09:52	Cardiovascular Imagings and Tests in Pregnant Women	김현진 / 한양의대
09:52-10:10	Discussion

[ACHD 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.205
Belated Diagnosis of PDA in Adult with CHD
Chairperson(s)	강이석
Panel	강웅철, 이병권
08:40-08:52	What to Do for Small PDA in ACHD	박재형 / 충남의대
08:52-09:04	What to Do for Large PDA in ACHD	송진영 / 성균관의대
09:04-09:16	Severe Pulmonary Hypertension with PDA in ACHD	김경희 / 인천세종병원
09:16-09:25	Discussion

[ACHD 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.205
Where Are We Now in Pulmonary Valve Implantation
Chairperson(s)	이형두
Panel	고훈, 장소익
09:35-09:47	Update for PPVI with PULSTA	김기범 / 서울의대
09:47-09:59	Echocardiographic Imaging Assessment before PPVI	차슬기 / 울산의대
09:59-10:11	Cardiac Rehabilitation in ACHD	은영민 / 연세의대
10:11-10:20	Discussion

[ACC Together with KSC (Imaging)]		Apr. 15 (Fri.) 10:30-11:15 Rm.300C
Chest Pain Guidelines from Cardiovascular Imaging Perspective
Chairperson(s)	Aaron Kugelmass, Andy Wai Khong Chan
10:30-10:40	Cardiac CT Imaging	Sumbal Janjua / MedStar Washington Hospital Centre, USA
10:40-10:50	CMR	Eui-Young Choi / Yonsei Univ., Korea
10:50-11:00	Nuclear Imaging	Prem Soman / Univ. of Pittsburgh, USA
11:00-11:10	Echocardiography	Judy Hung / Harvard Medical School, USA
11:10-11:15	Discussion

[ACC Together with KSC/KSoLA]		Apr. 15 (Fri.) 11:25-12:10 Rm.300C
Optimization of Cardiovascular Risk Factors to Prevent ASCVD in Specific Populations
Chairperson(s)	Nathan Wong, Soon Jun Hong
Panel	Anwar Santoso, Ung Kim
11:25-11:35	Optimization of CV Risk Factors for Women	Erin Michos / Johns Hopkins Univ. , USA
11:35-11:45	CV Risk Factor Optimization for Older Persons: Current Gaps and Future Directions	Noreen Nazir / Univ. of Illinois, USA
11:45-11:55	CV Risk Factor Optimization for Asians	Jung Ho Heo / Kosin Univ., Korea
11:55-12:10	Discussion

[ACC Together with KSC/KSIC 1]		Apr. 15 (Fri.) 10:30-11:15 Rm.102
Asymptomatic Severe AS
Chairperson(s)	Harold Dauerman, Hyo-Soo Kim
Panel	Duk Woo Park, Sung Ji Park, Sak Lee
10:30-10:42	What Do Guidelines Say for When to Intervene for Asymptomatic AS?	Kian Keong Poh / National Univ. of Singapore, Singapore
10:42-10:54	AVATAR and RECOVERY Trials: Should We Be Intervening Earlier?	Michael Rinaldi / Sanger Heart & Vascular Institute, USA
10:54-11:06	When To Do SAVR vs. TAVR for Severe AS	Peter Pollak / Mayo Clinic, USA
11:06-11:15	Discussion

[ACC Together with KSC/KSIC 2]		Apr. 15 (Fri.) 11:25-12:10 Rm.102
Challenging Valvular Cases
Chairperson(s)	Kian Keong Poh, Myeong Ki Hong
Panel	Jung-Sun Kim, Kiyuk Chang, Geu-Ru Hong
11:25-11:35	Case: Severe AS and Severe Calcific MS: What to Do with Mitral Valve When Intervening for AS?	Abdallah El Sabbagh / Mayo Clinic, USA
11:35-11:40	Discussion
11:40-11:50	The Pivot-TR Preclinical Data: How Easy Can a TR Device Go for The Procedure?	June Hong Kim / Pusan National Univ., Korea
11:50-11:55	Discussion
11:55-12:05	Case: 58 Year Old Male with BAV, Asymptomatic Severe AS (Peak and Mean 120/70 mmHg): What Type of Valve?	Molly Szerlip / Baylor Scott and White The Heart Hospital Plano, USA
12:05-12:10	Discussion

[ACC Together with KSC/KHRS 3]		Apr. 15 (Fri.) 10:30-11:15 Rm.103
Atrial Fibrillation Ablation: Who and When?
Chairperson(s)	Fred Kusumoto, Kee-Joon Choi
Panel	Hyoung-Seob Park
10:30-10:40	AFFIRM vs. EAST AFNet4: Why the Difference?	Boyoung Joung / Yonsei Univ., Korea
10:40-10:50	How Do I Select Heart Failure Patients to Refer to EP for Ablation?	Juan Carlos Leoni / Mayo Clinic, USA
10:50-11:00	What to Do After the First AF Ablation Fails?	Nassir Marrouche / Tulane Univ., USA
11:00-11:15	Discussion

[ACC Together with KSC (Myocardial Infarction)]		Apr. 15 (Fri.) 11:25-12:10 Rm.103
Emerging Trends in STEMI Care
Chairperson(s)	Aaron Kugelmass, Myung Ho Jeong
Panel	Junbo Ge
11:25-11:30	Intro
11:30-11:42	Emerging Issues and Therapies for STEMI in US	Kwan Lee / Univ. of Arizona, USA
11:42-11:54	Emerging Issues and Therapies for STEMI in Korea	Jang Hoon Lee / Kyungpook National Univ., Korea
11:54-12:10	Discussion

[Basic Research Hot Session 2]		Apr. 15 (Fri.) 10:30-12:10 Rm.105
Current Trends of Cardiovascular Research
Chairperson(s)	김치대, 최동훈
Panel	국현, 권유욱, 배순식
10:30-10:55	DII4 Suppresses Transcytosis for Arterial Blood-retinal Barrier Homeostasis	김인준 / KAIST
10:55-11:20	Application of Prime Editing to the Correction of Mutations and Phenotypes in Vascular Disease	조동현 / 서울의대
11:20-11:45	S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction	윤소미 / 전남대학교
11:45-12:00	Discussion

[Cardiogenic Shock]		Apr. 15 (Fri.) 10:30-11:15 Rm.203
Optimal Care in Patients with ECMO in Cardiogenic Shock
Chairperson(s)	권현철, 강석민
Panel	김진진, 오재원, 조현재, 최기홍
10:30-10:45	Optimal Management and Monitoring during ECMO in Patients with Cardiogenic Shock	정재승 / 고려의대
10:45-11:00	Optimal ECMO Weaning and Post-ECMO Care in Patients with Cardiogenic Shock	양정훈 / 성균관의대
11:00-11:15	Discussion

[Imaging]		Apr. 15 (Fri.) 11:25-12:10 Rm.203
Post-Ischemia Trial Era: Role Of Cardiac Imaging
Chairperson(s)	범희승, 최병욱
Panel	양동현, 팽진철
11:25-11:35	Clinical Practice in Post-Ischemia Trial Era	홍성진 / 연세의대
11:35-11:45	Role of CT Angiography (CT Perfusion)	김문영 / 서울의대
11:45-11:55	Role of Cardiac MRI	장성아 / 성균관의대
11:55-12:05	Role of Nuclear Cardiac Imaging	최준영 / 성균관의대
12:05-12:10	Discussion

[ACHD 3]		Apr. 15 (Fri.) 10:30-11:15 Rm.205
Extracardiac Problems in ACHD: We Need More Concerns
Chairperson(s)	박승우
Panel	장성아, 최은영
10:30-10:42	Abnormal Lung Function in Adults with Congenital Heart Disease	이현 / 한양의대
10:42-10:54	Hepatopathy in Adult with Congenital Heart Disease	이상윤 / 서울의대
10:54-11:06	Systemic Illness in Adult with Cyanotic Congenital Heart Disease	김민선 / 성균관의대
11:06-11:15	Discussion

[ACHD 4]		Apr. 15 (Fri.) 11:25-12:10 Rm.205
Long Term Prognosis of Complex Congenital Heart Disease
Chairperson(s)	허준
Panel	윤현주
11:25-11:37	Arterial Switch Operation	곽재건 / 서울의대
11:37-11:49	Ross Procedure	박천수 / 울산의대
11:49-12:01	Fontan Operation	양지혁 / 성균관의대
12:01-12:10	Discussion

[Diamond Session [Amgen]]		Apr. 15 (Fri.) 12:20-13:00 Rm.300C
LDL-C Management: From Hospitalization to Discharge in ACS Patients
Chairperson(s)	정명호, 박헌식
Panel	안준호, 이창훈
12:20-12:35	LDL-C Lowering Strategies in ACS Patients from Hospitalization	장영우 / 가천의대
12:35-12:50	Case Review: How to Use Evolocumab in My Practice	김병진 / 성균관의대
12:50-13:00	Discussion

[Diamond Session [Viatris]]		Apr. 15 (Fri.) 12:20-13:00 Rm.102
Lipitor Portfolio, Optimal Treatment for ACS Patients
Chairperson(s)	구본권
12:20-12:40	Early Bird of High Intensity Statin to Close the Gap between Theory and Practice in ACS Patients	방덕원 / 순천향의대
12:40-13:00	When and Why Combination Therapy Is Needed for Dyslipidemia Patients? As the Next Option of Maximum Tolerable Mono Statin Therapy	손정우 / 연세원주의대

[Scientific Session [Pfizer/BMS]]		Apr. 15 (Fri.) 12:20-13:00 Rm.103
Better Patient Care with Anticoagulation in AF and VTE
Chairperson(s)	김두일, 오세일
12:20-12:40	Anticoagulation Strategy for Elderly AF Patients with Comorbidities: Suggestion from Eliquis	이소령 / 서울의대
12:40-13:00	Anticoagulation Strategy for VTE Patients: Suggestion from Eliquis	오재원 / 연세의대

[Scientific Session [Boryung]]		Apr. 15 (Fri.) 12:20-13:00 Rm.105
New Insights in the Treatment of Hypertension
Chairperson(s)	강덕현, 하종원
12:20-12:40	Achieving Target Blood Pressure with Triple-combination Therapy, Dukarb Plus	홍영준 / 전남의대
12:40-13:00	New Clinical Outcome of Fimasartan in Korean Hypertensive Patients	이찬주 / 연세의대

[Scientific Session [Samjin] ]		Apr. 15 (Fri.) 12:20-13:00 Rm.203
Updates on Treatment Strategies for High-risk Patients
Chairperson(s)	우성일, 채인호
12:20-12:35	Review of HOST-EXAM: What Is Optimal Antiplatelet Therapy after DAPT for Undergoing PCI Patients?	강지훈 / 서울의대
12:35-12:50	Managing AF Patient Undergoing PCI: Focused on Rivaroxaban	정영훈 / 중앙의대
12:50-13:00	Discussion

[Scientific Session [Organon] ]		Apr. 15 (Fri.) 12:20-13:00 Rm.205
Early & Lower for Longer Through Intensity Statin and Ezetimibe for Lipid Management
Chairperson(s)	허승호
12:20-12:35	Early for Longer: Intensive Lipid Lowering - Moving beyond Statins Alone	김대희 / 울산의대
12:35-12:50	Lower for Longer: Effective Lipid Lowering - Rising on Ezetimibe Therapy	송영빈 / 성균관의대
12:50-13:00	Discussion

[Memorial Lecture]		Apr. 15 (Fri.) 13:10-13:50 Rm.300C
Chairperson(s)	Eugene Yang, 김효수
13:10-13:25	故 이성호 교수님 회고	오병희 / 인천세종병원
13:25-13:50	Cardiovascular Innovations/Future Talk	Ami Bhatt / Harvard Medical School, USA

[Scientific Session [Novartis]]		Apr. 15 (Fri.) 13:10-13:50 Rm.102
ARNI: 1st Choice for below Normal LVEF Heart Failure Patients
Chairperson(s)	오용석, 강석민
13:10-13:30	Expanding Role of Entresto for HF with below Normal EF	Gregg C. Fonarow / Ronald Reagan UCLA Medical Center, USA
13:30-13:50	Evolving Role of Entresto as First Choice for Your HF Patient	조현재 / 서울의대

[Scientific Session [Boehringer Ingelheim/Lilly]]		Apr. 15 (Fri.) 13:10-13:50 Rm.103
SGLT2 Inhibition in HFrEF; Digging Deeper and Treating Earlier
Chairperson(s)	홍명기, 유병수
13:10-13:30	Quantum Leaps with Empagliflozin from T2D to HFrEF	서존 / 순천향의대
13:30-13:50	Empagliflozin as An Early, First Line Therapy in Patients with HFrEF	조재영 / 전남의대

[Scientific Session [Bayer]]		Apr. 15 (Fri.) 13:10-13:50 Rm.105
Heart and Brain in High-Risk Vascular Disease Patients. Let`s Complete the Puzzle!
Chairperson(s)	이문형, 나승운
13:10-13:30	How to Protect Vascular Events in NVAF Patients with DM	최의근 / 서울의대
13:30-13:50	How to Protect Patients with Poly-vascular Disease	김병극 / 연세의대

[Scientific Session [Celltrion Pharm/Dong-A ST]]		Apr. 15 (Fri.) 13:10-13:50 Rm.203
Benefits of Intensive & Consistent BP Control for Reducing CVD Risk
Chairperson(s)	최동주, 최기준
13:10-13:30	Importance of 24h BP Control for Reducing CVD Risk; The Role of Edarbi	최정현 / 부산의대
13:30-13:50	Intensive Treatment Strategy in Hypertension	박지영 / 을지의대

[Insurance Issues]		Apr. 15 (Fri.) 14:00-15:30 Rm.300C
3차 상대가치 조정과 시술 영역의 신설
Chairperson(s)	오동진, 배장환
Panel	김진배, 서존, 최성훈
14:00-14:15	내소정 입원 진료료 가산 관련 문제점 - 3차 상대가치 기본진료료 개편 방안	김병옥 / 인제의대
14:15-14:30	3차 상대가치 조정-영상 검체검사 가산 삭제의 문제점과 개선방향	조덕규 / 연세의대
14:30-14:45	Discussion
14:45-15:00	심혈관계 시술을 인터벤션 영역으로의 독립-의협의 입장	전로원 / 전로원내과
15:00-15:15	심혈관계 시술을 인터벤션 영역으로의 독립-정부의 입장	조영대 / 보건복지부
15:15-15:30	Discussion

[Myocardial Infarction 1]		Apr. 15 (Fri.) 14:55-15:40 Rm.105
Tough Calls during AMI PCI
Chairperson(s)	박헌식, 차광수
Panel	김정수, 윤경호, 윤창환, 이상엽
14:55-15:07	How to Find Culprit Lesion and Manage Non-Culprit Lesion: Imaging and Physiology	김현국 / 조선의대
15:07-15:19	How to Overcome Coronary Thrombosis during Primary PCI	윤영진 / 연세원주의대
15:19-15:31	Which Is the First Strategy in AMI with Cardiogenic Shock: VA-ECMO or PCI?	장우진 / 이화의대
15:31-15:40	Discussion

[Smart Health]		Apr. 15 (Fri.) 14:00-14:45 Rm.203
How to Use Wearable Devices?
Chairperson(s)	박승우, 박성하
Panel	김성환, 심재민
14:00-14:10	How to Set Up ECG Patch Devices in My Hospital?	조영진 / 서울의대
14:10-14:20	Can I Use a Smart Watch or a Ring-type Device in My Clinic?	김준 / 울산의대
14:20-14:30	Clinical Use of a Life-style ECG Device	권준명 / 인천세종병원
14:30-14:45	Discussion

[Basic Research 1]		Apr. 15 (Fri.) 14:00-15:30 Rm.205
How to Perform Good Cardiovascular Basic and Translational Research?
Chairperson(s)	오구택, 민필기
Panel	권유욱, 김용숙, 이상학, 임상현
14:00-14:20	심장 기초중개 연구 국책과제 연구비를 수주하기 위한 노하우	박훈준 / 가톨릭의대
14:20-14:40	좋은 심장 기초중개 연구를 위한 노하우 - 기초의과학자 입장	김형규 / 인제의대
14:40-15:00	좋은 심장 기초중개 연구를 위한 노하우 - 임상의사 입장	오재원 / 연세의대
15:00-15:20	How Big Data Changes the Biomedical Research?	박현영 / 국립보건연구원
15:20-15:30	Discussion

[Healthcare Policy]		Apr. 15 (Fri.) 15:50-17:20 Rm.300C
심장내과 분과전문의 수급에 대한 현안과 대책
Chairperson(s)	정중화, 김성환
Panel	김세은, 나진오, 박태호, 최진아
15:50-16:10	심장내과 의료인력 현황과 문제점	유승기 / 을지의대
16:10-16:30	학문후속세대 감소의 원인	김진배 / 경희의대
16:30-16:50	학문후속세대 감소의 대책	김송이 / 제주의대
16:50-17:20	Discussion

[Myocardial Infarction 2]		Apr. 15 (Fri.) 15:50-16:35 Rm.105
Controversial Issues for the Treatment of AMI
Chairperson(s)	정명호, 황진용
Panel	김병극, 배장환, 이장훈, 임용환
15:50-16:05	Shortening DAPT Duration for AMI: Is It Safe or Not?	한주용 / 성균관의대
16:05-16:20	Lowering LDL As Possible As You Can: Is It Working or Not?	김원 / 경희의대
16:20-16:35	Discussion
16:35-16:50	Complete Revascularization for AMI Complicating Cardiogenic Shock: In the Case of MCS	김민철 / 전남의대
16:50-17:05	Novel Pharmacotherapy for HF after AMI: SGLT2, ARNI - Initial Strategy vs. Last Resort?	이상록 / 전북의대
17:05-17:20	Discussion

[Epidemiology]		Apr. 15 (Fri.) 15:50-16:35 Rm.203
CVD Epidemiology Study Using National Health Insurance Big Data
Chairperson(s)	김현창, 최종일
15:50-16:00	Hypertension and CVD Risk	이호규 / 연세의대
16:00-16:10	CVD Risk in Cancer Survivors	윤종찬 / 가톨릭의대
16:10-16:20	Prevention and Prognosis of Atrial Fibrillation	이소령 / 서울의대
16:20-16:30	Lifestyle Risk Factors of CVD	신동욱 / 성균관의대
16:30-16:35	Discussion

[Basic Research 2]		Apr. 15 (Fri.) 15:50-17:20 Rm.205
How to Make IHD and HF Model for Basic and Translational Cardiovascular Research?
Chairperson(s)	안영근, 한진
Panel	우선희, 조성우, 주형준, 한승환
15:50-16:10	Murine and Rodent Model	이승준 / 연세의대
16:10-16:30	Pig Model	임경섭 / 한국생명공학연구원
16:30-16:50	In Vitro Model: Cell Line and Patient Specific iPSC-derived Cardiovascular Cell	양한모 / 서울의대
16:50-17:10	Electrophysiology and Echocardiography Evaluation in Animal Model	고태희 / 고려의대
17:10-17:20	Discussion

[ACC Together with KSC (Education Workshop 1)]		Apr. 16 (Sat.) 08:00-08:45 Rm.300C
Wide Complex Tachycardia
Chairperson(s)	Zachary Goldberger, Young-Hoon Kim
Panel	Hean Yee Ong, Jaemin Shim, Sung-Won Jang
08:00-08:15	Lecture	Fred Kusumoto / Mayo Clinic, USA
08:15-08:45	ECG Examples	Fred Kusumoto / Mayo Clinic, USA

[ACC Together with KSC (Education Workshop 2)]		Apr. 16 (Sat.) 08:55-09:40 Rm.300C
Contemporary Approaches to Stable Ischemic Heart Disease
Chairperson(s)	Yuk-Kong Lau, Bon-Kwon Koo
Panel	Junbo Ge, Alan Yean Yip Fong , Young Joon Hong
08:55-09:10	Evaluation/Diagnosis of Stable Ischemic Heart Disease	Jung-Min Ahn / Ulsan Univ., Korea
09:10-09:25	Treatment Paradigms	Kwan Lee / Univ. of Arizona, USA
09:25-09:40	Discussion

[ACC Together with KSC/KSE 3]		Apr. 16 (Sat.) 08:00-08:45 Rm.102
The Tricuspid Valve: Forgotten No More
Chairperson(s)	Harold Dauerman, Jong-Won Ha
Panel	Sung Hee Shin, Iksung Cho
08:00-08:12	How to Assess the Prognosis of TR	Jun-Bean Park / Seoul National Univ., Korea
08:12-08:24	Imaging of the TV, Echocardiography and More	Jin Sun Park / Ajou Univ., Korea
08:24-08:36	Overview of Percutaneous TV Devices	Tsuyoshi Kaneko / Brigham and Women’s Hospital, USA
08:36-08:45	Discussion

[ACC Together with KSC/KSE 4]		Apr. 16 (Sat.) 08:55-09:40 Rm.102
CV Imaging in Heart Failure: How and When to Use Echo, CMR and CT?
Chairperson(s)	Ana Barac, Sang Hong Baek
Panel	Hean Yee Ong, Jin Oh Choi
08:55-09:05	Role of Echocardiography	David Dudzinski / Massachusetts General Hospital, USA
09:05-09:15	Role of CMR	Yeonyee E. Yoon / Seoul National Univ., Korea
09:15-09:25	Role of CT	Sang Eun Lee / Ewha Univ., Korea
09:25-09:40	Discussion

[ACC Together with KSC/KSHF 3]		Apr. 16 (Sat.) 08:00-08:45 Rm.103
Innovations in Heart Transplantation: What Does the Future Hold?
Chairperson(s)	Biykem Bozkurt
08:00-08:15	Heart Transplant Rejection Surveillance: Is It Time to Put Away Our Bioptomes?	Paul Mather / Univ. of Pennsylvania, USA
08:15-08:22	Discussion
08:22-08:37	Innovative Immunosuppressive Strategies: Improving Tolerance and Minimizing Side Effects	Kyung-Hee Kim / Incheon Sejong Hospital, Korea
08:37-08:45	Discussion

[ACC Together with KSC/KSHF 4]		Apr. 16 (Sat.) 08:55-09:40 Rm.103
HFpEF: Guidelines, Therapies, and Non-Pharmalogical Approaches
Chairperson(s)	Paul Mather, Byung Su Yoo
08:55-09:05	HFpEF in the Eyes of the European and U.S. Guidelines	Stuart Prenner / Univ. of Pennsylvania, USA
09:05-09:10	Discussion
09:10-09:20	Therapies for HFpEF: The Impact of SGLT2 Inhibitors and ARNI’s on the Disease Process	Jaewon Oh / Yonsei Univ., Korea
09:20-09:25	Discussion
09:25-09:35	Non-Pharmacological Approaches to Improving Symptoms and Exercise Capacity	Jagmeet Singh / Harvard Medical School, USA
09:35-09:40	Discussion

[ACC Together with KSC (Smart Health)]		Apr. 16 (Sat.) 08:00-08:45 Rm.105
Leveraging Technology for CV Prevention
Chairperson(s)	Nannette Rey, Yong-Jin Kim
Panel	Chang Hwan Yoon, Jong-Il Choi
08:00-08:10	Wearable Devices: Friend or Foe?	Il-Young Oh / Seoul National Univ., Korea
08:10-08:20	Remote Blood Pressure Monitoring: Does It Work?	Joseph Ebinger / Cedars-Sinai Medical Center, USA
08:20-08:30	Future Technologies for CV Prevention: Where Are We Headed?	Jun Beom Park / Ewha Univ., Korea
08:30-08:45	Discussion

[ACC Together with KSC/KSCMS]		Apr. 16 (Sat.) 08:55-09:40 Rm.105
Beyond LDL-C Lowering: Role of Non-Statin Therapies
Chairperson(s)	Eugenia Gianos, Kwang Kon Koh
Panel	Orlando Bugarin, Sang-Ho Jo
08:55-09:10	Overview of Non-Statin Therapies	Pamela Morris / Univ. of South Carolina, USA
09:10-09:15	Case: Fibrates	Jae Bin Seo / Seoul National Univ., Korea
09:15-09:20	Discussion
09:20-09:25	Case: Fish Oil, Icosapent Ethyl	Hyun-Jin Kim / Hanyang Univ., Korea
09:25-09:30	Discussion
09:30-09:35	Case: PCSK9 Inhibitors	Youngwoo Jang / Gachon Univ., Korea
09:35-09:40	Discussion

[Journal of the American College of Cardiology (JACC) Asia: Pulmonary Vascular Medicine]		Apr. 16 (Sat.) 08:00-08:45 Rm.205
Chairperson(s)	Zhi-Cheng Jing, Lewis J. Rubin
Panel	Keiko Takihara, Irene M. Lang, You-Yang Zhao, Wook-Jin Chung
08:00-08:02	Opening Remarks	Lewis J. Rubin / Columbia Univ. , USA
08:02-08:06	Pulmonary Vascular Disease Is also an Important Field Focused on by JACC: Asia	Jian-An Wang / Zhejiang Univ., China
08:06-08:13	Anatomy, Classification and Interventional Treatment of Pulmonary Vein Stenosis	Yun-Shan Cao / Gansu Provincial Hospital, China
08:13-08:20	PHOENIKS Platform, A Longitudinal PH Cohort Platform with Biobank for Multi-omics in Korea	Kyung Jin Ahn / Gachon Univ., Korea
08:20-08:27	Genetic Assessment for PAH: Challenging for the Precision Medicine in Asia	Takahiro Hiraide / Keio Univ., Japan
08:27-08:29	Discussion
08:29-08:33	Overview of the Publications on Pulmonary Vascular Diseases in JACC: Asia	Zong-Ye Cai / Zhejiang Univ., China
08:33-08:37	Case: Percutaneous Transluminal Pulmonary Angioplasty for a Patient with Takayasu’s Arteritis and Pulmonary Hypertension	Yu-Ping Zhou / Peking Union Medical College Hospital, China
08:37-08:41	Case: A PAH Case Associated with Qin-Dai (Induribin)	Fusako Sera / Osaka Univ., Japan
08:41-08:43	Discussion
08:43-08:45	Closing Remarks	Zhi-Cheng Jing / Peking Union Medical College Hospital, China

[ACC Together with KSC (Education Workshop 3)]		Apr. 16 (Sat.) 09:50-10:35 Rm.300C
Universal Definition of Heart Failure and the Impact on Your Practice
Chairperson(s)	Paul Mather, Seok Min Kang
Panel	Wook-Jin Chung, Jin Oh Choi
09:50-10:05	What Is New in the Universal Definition of Heart Failure? Summary and Implications	Biykem Bozkurt / Baylor College of Medicine, USA
10:05-10:20	How Will the New Definition and Staging Impact Practice and Care?	Kye Hun Kim / Chonnam National Univ., Korea
10:20-10:35	Discussion

[ACC Together with KSC (Education Workshop 4)]		Apr. 16 (Sat.) 10:45-11:30 Rm.300C
Latest in Valvular Heart Disease Management: 2020 ACC/AHA Valvular Heart Disease Guidelines Update
Chairperson(s)	Edgar Tay , Duk-Hyun Kang
Panel	Dae-Hee Kim, Seung Pyo Lee
10:45-11:02	Update on Aortic Stenosis and Regurgitation	Y.S. Chandrashekhar / Univ. of Minnesota, USA
11:02-11:19	Update on MR/MS	Katy Lease Lonergan / UT Southwestern Medical Center, USA
11:19-11:30	Discussion

[ACC Together with KSC (Hypertension)]		Apr. 16 (Sat.) 09:50-10:35 Rm.102
Hypertension Management in Older Persons: Intensive vs. Standard Treatment
Chairperson(s)	Gilbert Vilela, Sang Hyun Ihm
09:50-09:52	Pre-debate Audience Poll
09:52-10:02	Hypertension in Older Persons: Yes to Intensive Treatment	Seamus Whelton / Johns Hopkins Ciccarone Center,USA
10:02-10:12	Hypertension in Older Persons: No to Intensive Treatment	Kwang-il Kim / Seoul National Univ., Korea
10:12-10:15	Pro Rebuttal	Seamus Whelton / Johns Hopkins Ciccarone Center,USA
10:15-10:18	Con Rebuttal	Kwang-il Kim / Seoul National Univ., Korea
10:18-10:33	Post-debate Poll and Discussion

[ACC Together with KSC (Epidemiology)]		Apr. 16 (Sat.) 10:45-11:30 Rm.102
Cardiovascular Risk Assessment for Koreans: Opportunities for Improvement
Chairperson(s)	Laurence Sperling, Sang-Hyun Kim
10:45-10:50	Case: Current Korean CV Risk Assessment	Hyung Joon Joo / Korea Univ., Korea
10:50-11:00	ACC Pooled Cohort Equation: Does It Apply to Koreans?	Eugene Yang / Univ. of Washington, USA
11:00-11:10	CV Risk Assessment for Koreans: What Tools to Use	Hyeon Chang Kim / Yonsei Univ., Korea
11:10-11:20	Korean CV Risk Assessment: New Risk Calculators	Hokyou Lee / Yonsei Univ., Korea
11:20-11:30	Discussion

[ACC Together with KSC (Cardiogenic Shock)]		Apr. 16 (Sat.) 09:50-10:35 Rm.103
Advances in Cardiogenic Shock
Chairperson(s)	Aaron Kugelmass, Hyeon-Cheol Gwon
Panel	In-Cheol Kim, Chul-Min Ahn, Jeong Hoon Yang, Jae-Seung Jung
09:50-09:55	Intro
09:55-10:05	Learnings from Korean Cardiogenic Shock Study (RESCUE Registry)	Ki Hong Choi / Sungkyunkwan Univ., Korea
10:05-10:15	Diagnostic and Risk Stratification in Cardiogenic Shock	Min-Seok Kim / Ulsan Univ., Korea
10:15-10:25	Recent Update in Mechanical Circulatory Support in Cardiogenic Shock	Isman Firdaus / Harapan Kita Hospital, Indonesia
10:25-10:35	Discussion

[ACC Together with KSC (Vascular)]		Apr. 16 (Sat.) 10:45-11:30 Rm.103
Role of Cardiac Rehabilitation for CV Prevention
Chairperson(s)	Richard Josephson, Ki Chul Sung
Panel	Kai Huat Lam, Chi Young Shim, Sung Kee Ryu, Hae-Young Lee
10:45-10:55	Overview of Cardiac Rehabilitation	Melissa Tracy / Rush Univ., USA
10:55-11:05	Cardiac Rehabilitation during the COVID Pandemic	Alison Bailey / HCA Healthcare, USA
11:05-11:15	Does Telerehabilitation Work?	Seok Min Kang / Yonsei Univ., Korea
11:15-11:30	Discussion

[ACC Together with KSC/KHRS 4]		Apr. 16 (Sat.) 09:50-10:35 Rm.105
New Pacing Strategies: Leadless, His Bundle
Chairperson(s)	Fred Kusumoto, Sang Weon Park
Panel	Il-Young Oh
09:50-10:00	Leadless Pacing	Seung Jung Park / Sungkyunkwan Univ., Korea
10:00-10:10	Conduction Tissue Pacing	Win-Kuang Shen / Mayo Clinic, USA
10:10-10:20	Future of Pacing	Yong-Mei Cha / Mayo Clinic, USA
10:20-10:35	Discussion

[ACC Together with KSC/KHRS 5]		Apr. 16 (Sat.) 10:45-11:30 Rm.105
What Will Be New in 2025: Pulsed Field Ablation, Cardioneuroablation?
Chairperson(s)	Charles Jia-Yin Hou, Seil Oh
Panel	Jaemin Shim, Jae-Sun Uhm
10:45-10:55	New Technologies for Ablation	Anca Chiriac / Mayo Clinic, USA
10:55-11:05	New Ablation Targets: Focus on Cardioneuroablation	Rakesh Gopinathannair / Kansas City Heart Rhythm Institute, USA
11:05-11:15	New Devices for HF	Jagmeet Singh / Harvard Medical School, USA
11:15-11:30	Discussion

[Hypertension]		Apr. 16 (Sat.) 09:50-10:35 Rm.205
Obesity and Hypertension
Chairperson(s)	성기철, 박형규
Panel	이해영, 조은주
09:50-10:05	Obesity and Hypertension: Pathophysiologic Link	이상열 / 경희의대
10:05-10:20	Management of Obesity: Beyond Life Style Modifications	김보연 / 순천향의대
10:20-10:35	Discussion

[Vascular]		Apr. 16 (Sat.) 10:45-11:30 Rm.205
Vascular Health and Cardiac Rehabilitation (Endurance or High-intensity Interval Exercise?)
Chairperson(s)	정진옥, 김장영
Panel	박진선, 이찬주, 임영효, 조은주
10:45-10:57	Endurance Exercise: Mostly Good but a Few Concerns	주기찬 / ACSM Representative in Korea
10:57-11:09	High Intensity Interval Training for Patients with Cardiovascular Disease - Is It Safe?	제세영 / 서울시립대학교
11:09-11:14	Endurance Exercise (Rebuttal)	주기찬 / ACSM Representative in Korea
11:14-11:19	High Intensity Interval Training (Rebuttal)	제세영 / 서울시립대학교
11:19-11:30	Discussion

[Scientific Session [Viatris]]		Apr. 16 (Sat.) 11:40-12:20 Rm.300C
Stepwise Treatment Options for Dyslipidemia
Chairperson(s)	조병렬, 양태현
11:40-12:10	Individual Lipid Management Selecting the Optimal Drug for the Right Patient	Kausik Ray / Imperial College NHS Trust, UK
12:10-12:20	Discussion

[Scientific Session [Amgen]]		Apr. 16 (Sat.) 11:40-12:20 Rm.102
Guideline-directed Lipid Lowering Therapy for ACS Patients
Chairperson(s)	배장환, 김병극
Panel	박명수, 오준혁
11:40-11:55	Guideline-based Strategy in Lipid Treatment Optimization After ACS: When to Check?	김민철 / 전남의대
11:55-12:10	Clinical Differentiation of Evolocumab in LDL-C Management	이원재 / 서울의대
12:10-12:20	Discussion

[Scientific Session [Hanmi]]		Apr. 16 (Sat.) 11:40-12:20 Rm.103
Strategies for Atherosclerosis Prevention in Dyslipidemia Patients with Hypertension
Chairperson(s)	김효수, 이철환
11:40-12:00	The Recent Trend of Hypertension Management Focused on Intensive & Comorbid Treatment	이한철 / 부산의대
12:00-12:20	Why Should We Consider Rosuvastatin+Ezetimibe Combination	김원 / 경희의대

[Scientific Session [Daiichisankyo/Daewoong]]		Apr. 16 (Sat.) 11:40-12:20 Rm.105
Update on Diagnosis and Treatment of High Risk Patients of Hypertension and AF
Chairperson(s)	박희남, 임상현
11:40-12:00	Update on Evidence-based Management of High Risk Patients with Hypertension	이해영 / 서울의대
12:00-12:20	Update on NOAC Management of Very High-risk Patient with AF	최의근 / 서울의대

[Scientific Session [Yuhan]]		Apr. 16 (Sat.) 11:40-12:20 Rm.203
A.I-based Wearable Electrocardiography
Chairperson(s)	김영훈
11:40-12:20	Holter vs. Wearable Patch for Arrhythmia Evaluation	오일영 / 서울의대

[Scientific Session [JW－Pharma]]		Apr. 16 (Sat.) 11:40-12:20 Rm.205
Optimal Management of Dislipidemia: Newest Evidence from Pitavastatin and Ezetimibe
Chairperson(s)	김기식, 한규록
11:40-12:00	Are Statins All the Same in Outcome and Safety for Asian?	이승환 / 울산의대
12:00-12:20	Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy	이종영 / 성균관의대

[Plenary Lecture]		Apr. 16 (Sat.) 12:30-13:15 Rm.300C
Chairperson(s)	Dipti Itchhaporia, Myeong-Chan Cho
12:30-13:15	Interventional Therapy: What’s Next	Roxana Mehran / Mount Sinai, USA

[Cardiac Pathology]		Apr. 16 (Sat.) 13:20-14:50 Rm.103
Myocarditis in COVID-19 Pandemic
Chairperson(s)	서정욱
Panel	은영민, 이상한, 차슬기
13:20-13:40	Pathology of Myocarditis	김정선 / 성균관의대
13:40-14:00	COVID-19 Myocarditis, Clinical Spectrum	김인철 / 계명의대
14:00-14:20	COVID-19 Myocarditis, Pathologic Spectrum	고지원 / 서울의대
14:20-14:40	A Clinician's Approach and Management of Myocarditis	강지훈 / 서울의대
14:40-14:50	Discussion

[Cardio - Oncology]		Apr. 16 (Sat.) 13:20-14:50 Rm.203
Immunotherapy and Emerging Cardiotoxicity
Chairperson(s)	손일석, 이윤규
Panel	김학진, 박찬석, 정우백
13:20-13:40	Monoclonal Antibody and Cardiotoxicty for Cardiologists	변자민 / 서울의대
13:40-14:00	CAR-T and Potential Cardiotoxicity for Cardiologists	박성수 / 가톨릭의대
14:00-14:20	Immune Check Point Inhibitor and Cardiotoxicity for Cardiologists	박세훈 / 성균관의대
14:20-14:40	Immnunotherapy Related Cardiotoxicity: Cardiologist's View	김은경 / 성균관의대
14:40-14:50	Discussion

[Cardiac Surgery]		Apr. 16 (Sat.) 13:20-14:50 Rm.205
Optimal Revascularization Strategy of CABG
Chairperson(s)	지현근, 윤영남
Panel	강도윤, 손석호, 이교선
13:20-13:40	Discrepancy in FFR-guided PCI and FFR-guided CABG	남창욱 / 계명의대
13:40-14:00	Current Evidence of Functional Ischemia-based CABG	황호영 / 서울의대
14:00-14:20	Total Arterial Revascularization Using Right ITA	이기종 / 연세의대
14:20-14:50	Discussion

[Education Workshop 5]		Apr. 16 (Sat.) 15:00-16:30 Rm.300C
Updates in Atrial Fibrillation Diagnosis and Management
Chairperson(s)	김남호, 온영근
Panel	이지현, 황종민
15:00-15:15	심방세동 기전 및 위험인자 관리	이기홍 / 전남의대
15:15-15:30	심방세동 스크리닝과 진단	임우현 / 서울의대
15:30-15:45	심방세동 뇌졸중 예방을 위한 항응고 최신 지견	박종성 / 동아의대
15:45-16:00	항부정맥약제를 이용한 심방세동 약물 치료	심재민 / 고려의대
16:00-16:15	심방세동 도자절제술을 이용한 리듬 조절 전략	엄재선 / 연세의대
16:15-16:30	Discussion

[Education Workshop 6]		Apr. 16 (Sat.) 16:40-18:10 Rm.300C
Take a First Step for TAVR
Chairperson(s)	고영국, 최승혁
Panel	국형돈, 김정수, 원호연, 진한영
16:40-16:55	Pre-Procedural Planning for TAVR	김주한 / 전남의대
16:55-17:10	Decision for Balloon-expandable vs Self-expandable Valve in TAVR	이중희 / 연세원주의대
17:10-17:25	Step-by-step TAVR Procedure	박덕우 / 울산의대
17:25-17:40	TAVR for Young and/or Low Risk Patients	김웅 / 영남의대
17:40-17:55	Optimal Antithrombotic Treatment after TAVR	황병희 / 가톨릭의대
17:55-18:10	Discussion

[abstract test]		Apr. 16 (Sat.) 12:30-13:15 Rm.102
12:30-12:35
12:35-12:40
12:40-12:45